Site içinde arama yapın | Boycat

Site içinde arama yapın

Ates Karahan @ateskarhan bir ses eklendi in Other
2026-06-24 13:46:53 · Translate ·

Dual GIP/ GLP-1 Receptor Agonists Obesity Drugs Market Opportunity Analysis Report

According to the latest report published by Data Bridge Market Research, the Dual GIP/ GLP-1 Receptor Agonists Obesity Drugs Market The global dual GIP/ GLP-1 receptor agonists obesity drugs market size was valued at USD 4.75 billion in 2024 and is expected to reach USD 17.71 billion by 2032, at a CAGR of 17.85% during the forecast period The persuasive Dual GIP/ GLP-1 Receptor...

0 Yorumlar ·0 hisse senetleri ·251 Views ·0 önizleme

Please log in to like, share and comment!
Aarya Jain @ThePolarisInsight bir ses eklendi in Other
2026-03-09 06:01:56 · Translate ·

Beyond Glycemic Control: Cardiovascular and Renal Benefits Expanding the GLP-1 Market Opportunity

A new growth forecast report titled GLP-1 Market Size, Share, & Industry Analysis Report: By Route of Administration (Oral and Parenteral), By Type of Molecule, By Active Compound Used, By Type of GLP-1 Agonist Drug, By Target Indication, and By Region – Market Forecast, 2025–2034 introduced by Polaris Market Research represents conclusive data on the overall market. It majorly...

0 Yorumlar ·0 hisse senetleri ·1K Views ·0 önizleme

Please log in to like, share and comment!
Sandeep Gade @sandeepg bir ses eklendi in Other
2026-06-29 20:32:14 · Translate ·

GLP-1 Analogues Market Set to Surpass USD 211.8 Billion by 2035 as Demand for Diabetes and Obesity Therapies Accelerates

The global GLP-1 analogues market is witnessing remarkable growth as the burden of type 2 diabetes and obesity continues to rise worldwide. Valued at US$ 51.6 billion in 2024, the market is projected to reach US$ 211.8 billion by 2035, registering a robust CAGR of 13.7% during the forecast period from 2025 to 2035. This impressive expansion reflects the growing adoption of GLP-1 receptor...

0 Yorumlar ·0 hisse senetleri ·219 Views ·0 önizleme

Please log in to like, share and comment!
Sandeep Gade @sandeepg bir ses eklendi in Other
2026-06-26 16:23:58 · Translate ·

GLP-1 Analogues Market Set to Surpass USD 211.8 Billion by 2035 as Diabetes and Obesity Cases Rise Globally

The global GLP-1 analogues market is undergoing a transformative phase, fueled by the growing burden of type 2 diabetes, obesity, and cardiometabolic disorders worldwide. According to recent market estimates, the industry was valued at US$ 51.6 billion in 2024 and is expected to reach US$ 211.8 billion by 2035, growing at a robust CAGR of 13.7% from 2025 to 2035. GLP-1...

0 Yorumlar ·0 hisse senetleri ·186 Views ·0 önizleme

Please log in to like, share and comment!
Emma Verghise @emmaverghise bir ses eklendi in Health
2026-06-15 05:32:00 · Translate ·

GLP-1 Analogues Market Size to Surpass New Milestones Amid Rising Diabetes and Obesity Cases

The global GLP-1 Analogues Market is experiencing unprecedented growth as healthcare providers increasingly adopt innovative therapies to address the rising burden of type 2 diabetes, obesity, and metabolic disorders. Growing clinical evidence supporting the effectiveness of glucagon-like peptide-1 (GLP-1) receptor agonists, expanding treatment indications, and increasing patient awareness are...

0 Yorumlar ·0 hisse senetleri ·380 Views ·0 önizleme

Please log in to like, share and comment!
Ajay Mane @ajaymane bir ses eklendi in Food
2026-06-09 17:16:25 · Translate ·

GLP-1 Hydration Products Market Set to Reach USD 5.8 Billion by 2036 Amid Rising Consumer Demand

NEWARK, Del., June 9, 2026 — The global GLP-1 Hydration Products Market is projected to grow from USD 1.2 billion in 2026 to USD 5.8 billion by 2036, registering a robust CAGR of 17.0% during the forecast period, according to Future Market Insights (FMI). The rapid adoption of GLP-1 receptor agonist therapies for weight management and metabolic health is creating a new category of...

0 Yorumlar ·0 hisse senetleri ·356 Views ·0 önizleme

Please log in to like, share and comment!
Aarya Jain @ThePolarisInsight bir ses eklendi in Health
2026-04-22 06:21:18 · Translate ·

GLP-1 Market Industry Trends and Global Forecast Report

Ozempic: Transforming Diabetes Care and Driving Growth in the GLP-1 Market Ozempic has become one of the most recognized pharmaceutical breakthroughs in recent years, redefining the management of type 2 diabetes and influencing the broader landscape of metabolic health. As a brand name for the drug semaglutide, Ozempic belongs to the class of glucagon-like peptide-1 (GLP-1) receptor agonists,...

0 Yorumlar ·0 hisse senetleri ·861 Views ·0 önizleme

Please log in to like, share and comment!
Aarya Jain @ThePolarisInsight bir ses eklendi in Health
2026-03-20 07:37:37 · Translate ·

GLP-1 Market Innovation Enhancing Patient Outcomes

Polaris Market Research has introduced the latest market research report titled GLP-1 Market Size, Share, & Industry Analysis Report: By Route of Administration (Oral and Parenteral), By Type of Molecule, By Active Compound Used, By Type of GLP-1 Agonist Drug, By Target Indication, and By Region – Market Forecast, 2026–2034 that highlights the major revenue stream for...

0 Yorumlar ·0 hisse senetleri ·1K Views ·0 önizleme

Please log in to like, share and comment!
Aarya Jain @ThePolarisInsight bir ses eklendi in Other
2026-02-17 10:24:41 · Translate ·

GLP-1 Market Trends: Tirzepatide, Semaglutide, and Next-Generation Dual/Triple Agonists

The latest business intelligence report released by Polaris Market Research on GLP-1 Market Size, Share, & Industry Analysis Report: By Route of Administration (Oral and Parenteral), By Type of Molecule, By Active Compound Used, By Type of GLP-1 Agonist Drug, By Target Indication, and By Region – Market Forecast, 2025–2034. It covers the in-depth knowledge of the GLP-1 Market...

0 Yorumlar ·0 hisse senetleri ·2K Views ·0 önizleme

Please log in to like, share and comment!
Ajay Mane @ajaymane bir ses eklendi in Food
2026-05-13 17:00:15 · Translate ·

GLP-1 Meal Replacement Market Value and Volume Forecast By FMI

NEWARK, Del., USA | May 13, 2026 — According to Future Market Insights (FMI), the global GLP-1 meal replacement market is witnessing rapid expansion, driven by growing adoption of GLP-1 medications, rising consumer preference for nutrient-dense meal formats, and increasing demand for convenient nutrition solutions tailored to reduced-appetite lifestyles. The market is also benefiting from...

0 Yorumlar ·0 hisse senetleri ·716 Views ·0 önizleme

Please log in to like, share and comment!
Emma Verghise @emmaverghise bir ses eklendi in Health
2026-03-13 20:50:53 · Translate ·

Increasing Adoption of Injectable and Oral GLP-1 Therapies Driving Market Growth

Polaris Market Research has introduced the latest market research report titled GLP-1 Receptor Agonist Market Size, Share, & Industry Analysis Report: By Route of Administration (Parenteral and Oral), By Product, By Application, By Distribution Channel, and By Region – Market Forecast, 2025–2034 that highlights the major revenue stream for the forecast period. The...

0 Yorumlar ·0 hisse senetleri ·2K Views ·0 önizleme

Please log in to like, share and comment!
Komal Galande @komal007 bir ses eklendi in Causes
2026-07-08 04:57:45 · Translate ·

Amylin Analog Market Advances with Growing Diabetes Management Innovations

According to the latest report published by Data Bridge Market Research, the Amylin Analog Market CAGR Value This Amylin Analog Marketresearch report is structured by performing the systematic, objective and exhaustive study of the facts related to several subjects in the field of marketing. This market research report provides relevant and specific information to the decision...

0 Yorumlar ·0 hisse senetleri ·86 Views ·0 önizleme

Please log in to like, share and comment!
Shikha Sharma @Shikhasharma03 bir ses eklendi in Other
2026-06-17 15:32:56 · Translate ·

Diabetes Treatments Market Size, Share, and Growth Forecast to 2030

According to the latest report published by Data Bridge Market Research, the Diabetes Treatments Market Data Bridge Market Research analyses that the global diabetes treatments market which was USD 5,370.2 million in 2022, would rocket up to USD 8,920.9 million by 2030, and is expected to undergo a CAGR of 6.5 % during the forecast period. Type-1 segment dominates the type segment of...

0 Yorumlar ·0 hisse senetleri ·5K Views ·0 önizleme

Please log in to like, share and comment!

Arama Sonuçları